David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA, Clinical Pharmacist Specialist in Infectious Diseases/HIV at Temple University Hospital (TUH), and T. Sam Albanesi, MD, Infectious Diseases Fellow at TUH, wrote an article for Contagion Live about lenacapavir, a new antiretroviral for the treatment of multi-drug resistant HIV-1 infection.
IMPORTANT: Beginning at 8:00 AM on September 3, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH